Literature DB >> 3839932

Preoperative adjuvant chemotherapy (neoadjuvant) for carcinoma of the breast: rationale and safety report.

J Ragaz, R Baird, P Rebbeck, A Goldie, A Coldman, J Spinelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3839932     DOI： 10.1007/978-3-642-82432-6_11

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  3 in total

1.  Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.

Authors:  Ying L Liu; Anurag Saraf; Shing M Lee; Xiaobo Zhong; Hanina Hibshoosh; Kevin Kalinsky; Eileen P Connolly
Journal:  Breast Cancer Res Treat       Date:  2016-05-25       Impact factor: 4.872

Review 2.  Neoadjuvant Therapy for Hepatocellular Carcinoma.

Authors:  Zongyi Yin; Dongying Chen; Shuang Liang; Xiaowu Li
Journal:  J Hepatocell Carcinoma       Date:  2022-08-31

Review 3.  Systemic therapy for early-stage breast cancer: learning from the past to build the future.

Authors:  Elisa Agostinetto; Joseph Gligorov; Martine Piccart
Journal:  Nat Rev Clin Oncol       Date:  2022-10-17       Impact factor: 65.011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.